Torrent Pharma's Q1 FY24 Reports Strong Profits

8 Aug 2023 , 11:55 AM

Torrent Pharmaceuticals Ltd. announced a Rs 378 crore consolidated net profit for Q1 FY24, showing a 7% increase compared to last year. The company’s total revenue for the quarter reached Rs 2,591 crore, up from Rs 2,347 crore in the same period last year.

Earnings before interest, tax, depreciation, and amortisation (Ebitda) stood at Rs 791 crore, with an Ebitda margin of 31%. Torrent Pharma achieved a net profit margin of Rs 14.6% during the quarter. The company spent Rs 129 crore, marking a 6% YoY increase.

The company’s operations in India reported a 15% growth in revenue, reaching Rs 1,426 crore from Rs 1,245 crore in Q1 FY23. The Curatio portfolio, especially in diabetes therapy and PCPM categories, contributed to this growth

For feedback and suggestions, write to us at [e-mail]